Journal of Vascular Nursing
Volume 24, Issue 4 , Pages 102-115 , December 2006

Lower limb atherosclerotic disease causes various deteriorations of patients’ health-related quality of life

  • Kirsi Koivunen, RN, MNSc

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Kirsi Koivunen, RN, MNSc, Department of Nursing Science and Health Administration, Faculty of Medicine, PO Box 5000, FIN-90014 University of Oulu, Finland.
    • ,
  • Hannele Lukkarinen, RN, PhD

References 

  1. Addington-Hall J, Kalra L. Who should measure quality of life?. In:  Carr AJ,  Higginson J,  Robinson PG editor. Quality of life. London: BMJ Books; 2003;p. 54–62
  2. Chen HS. Practical program evaluation: assessing and improving planning, implementation, and effectiveness. Thousand Oaks, CA: Sage Publications; 2005;
  3. Mätzke S, Peräkylä T, Lepäntalo M. Intermittent claudication or critical ischaemia. Duodecim. 1996;113:1997–2001(Finnish)
  4. Diehm C, Kareem S, Lawall H. Epidemiology of peripheral arterial disease. Vasa. 2004;33:183–189
  5. Burns P, Gough S, Bradbury AW. Management of peripheral arterial disease in primary care. Br Med J. 2003;326:584–588
  6. Selvin E, Erlinger TP. Prevalence of and risk factors of peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110:738–743
  7. Treat-Jacobson D, Halverson SL, Ratchford A, et al. A patient-derived perspective of health- related quality of life with peripheral arterial disease. J Nurs Scholarsh. 2002;34:55–60
  8. Holler D, Claes C, von der Schulenburg JM. Treatment costs and quality of life of patients with peripheral arterial occlusive disease. Vasa. 2004;33:145–153
  9. Goodal S. Peripheral vascular disease. Nurs Stand. 2000;14:48–54
  10. Bick C. Intermittent claudication. Nurs Stand. 2003;17:45–55
  11. Cimminiello C. PAD—epidemiology and pathophysiology. Thromb Res. 2002;106:V295–V301
  12. Murabito JM, Evans JC, Larson MG, et al. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med. 2003;163:1939–1942
  13. Dormandy JA, Rutherford RB TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease. J Vasc Surg. 2000;31:S1–S296
  14. Hirsch A, Crique MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–1324
  15. Ouriel K. Peripheral arterial disease. Lancet. 2001;358:1257–1264
  16. Fine JJ, Hall PA, Richardson JH. Predictive power of cardiovascular risk factors for detecting peripheral vascular disease. South Med J. 2004;97:951–954
  17. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333–3341
  18. Faxon DP, Cochair FV, Cochair LP, et al. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation. 2004;109(21):2617–2625
  19. Halperin J, Fuster V. Meeting the challenge of peripheral arterial disease. Arch Intern Med. 2003;163:877–878
  20. Al-Delaimy WK, Merchant AT, Rimm EB, et al. Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med. 2004;116:236–240
  21. Lu JT, Creager MA. The relationship of cigarette smoking to peripheral arterial disease. Rev Cardiovasc Med. 2004;5:189–193
  22. Meijer WT, Grobbee DE, Hunink MGM, et al. Determinants of peripheral arterial disease in the elderly: the Rotterdam Study. Arch Intern Med. 2000;160:2934–2938
  23. Chiu JH, Topol EJ, Whitlow PL, et al. Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization. Am J Cardiol. 2003;92:582–583
  24. WHOQOL Group. Annotated Bibliography of the WHO Quality of Life Assessment Instrument—WHOQOL. Rev. 2. World Health Organization. Department of Mental Health. Switzerland 1998. Available at: http://depts.washington.edu/yqol/docs/WHOQOL_Bibliography.pdf. Accessed October 1999.
  25. Bowling A. Current state of the art in quality of life measurement. In:  Carr AJ,  Higginson IJ,  Robinson PG editor. Quality of life. London: BMJ Books; 2003;p. 1–8
  26. Bowling A. Measuring health (A review of quality of life measurement scales). 3rd ed.. England: Open University Press; 2005;
  27. Carlon R, Morlino T, Maiolino P. Beneficial effects of exercise beyond the pain threshold in intermittent claudication. Ital Heart J. 2003;4(2):113–120
  28. Cheetham DR, Burgess L, Ellis M, et al. Does supervised exercise offer adjuvant benefit over exercise advice alone for the intermittent claudication? (A randomised trial). Eur J Vasc Endovasc Surg. 2004;27(1):17–23
  29. Oka RK, Altman M, Giacomini JC, et al. Exercise patterns and cardiovascular fitness of patients with peripheral arterial disease. J Vasc Nurs. 2004;22:109–114
  30. Menard JR, Smith HE, Riebe D, et al. Long-term results of peripheral arterial disease rehabilitation. J Vasc Surg. 2004;39:1186–1192
  31. Whyman MR, Fowkes FGR, Kerracher EMG, et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? (A randomized controlled trial). J Vasc Surg. 1997;26:551–557
  32. Bosch JL, van der Graaf Y, Hunink MGM. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease. Circulation. 1999;99:3155–3160
  33. Donaghue CC, Bohannon RW, Maljanian R, et al. Improved health-related quality of life 12 months after bypass or angioplasty for peripheral arterial disease. J Vasc Nurs. 2000;18:75–82
  34. Chetter IC, Spark JI, Scott DJ, et al. Prospective analysis of quality of life in patients following infrainguinal reconstruction for chronic critical ischaemia. Br J Surg. 1998;85:951–955
  35. De Graaff JC, Ubbink DT, Kools EJC, et al. The impact of peripheral and coronary artery disease on health related quality of life. Ann Vasc Surg. 2002;16:495–500
  36. Thorsen H, McKenna S, Tennant A, et al. Nottingham Health Profile scores predict the outcome and support aggressive revascularization for critical ischaemia. Eur J Vasc Endovasc Surg. 2002;23:495–499
  37. Khaira HS, Hanger R, Shearman CP. Quality of life patients with intermittent claudication. Eur J Vasc Endovasc Surg. 1996;11:65–69
  38. Hicken GJ, Lossing AG, Ameli M. Assessment of generic health-related quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2000;20:336–341
  39. Johnstone CC. Living with peripheral vascular disease: patients and their carers. Nurs Times. 2004;100:36–39
  40. Wann-Hansson C, Hallberg IR, Klevsgard R, et al. Patients’ experiences of living with peripheral arterial disease awaiting intervention: a qualitative study. Int J Nurs Stud. 2005;42:851–862
  41. Klevsgård R, Hallbergz IR, Risberg B, et al. Quality of life associated with varying degrees of chronic lower limb ischaemia: comparison with a healthy sample. Eur J Vasc Endovasc Surg. 1999;17:319–325
  42. Breek JC, Hamming JF, De Vries J, et al. Quality of life in patients with intermittent claudication using the World Health Organization (WHO) questionnaire. Eur J Vasc Endovasc Surg. 2001;21:118–122
  43. Koivukangas P, Koivukangas J. Role of life in therapeutic strategies in brain tumors. Health Policy. 1988;10:241–257
  44. Koivukangas P. A two-wave mimic model for the construction of a health status index based on the health production function (Series C 69). Oulu: Acta Universitatis Ouluensis, Department of Economics, University of Oulu; 1993;
  45. Koivukangas P, Ohinmaa A, Koivukangas J. Nottingham Health Profilen suomalainen versio (a Finnish version of Nottingham Health Profile). Reports 187. STAKES. Saarijärvi: Gummerus Kirjapaino Oy; 1995;(Finnish)
  46. Lukkarinen H. Quality of life and life course of people with coronary artery disease. A longitudinal survey of patients treated with medication, transluminal angioplasty or bypass surgery. Series D 562. Oulu: Department of Nursing and Health Administration, University of Oulu; 1999;
  47. Hemmilä HM. Quality of life and cost of care of back pain patients in Finnish general practice. Spine. 2002;27:647–653
  48. Uutela T, Hakala M, Kautiainen H. Validity of the Nottingham Health Profile in a Finnish out-patient population with rheumatoid arthritis. Rheumatology. 2003;42:841–845
  49. Hunt SM, McKenna SP, McEven J, et al. The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med. 1981;15:221–229
  50. Wann-Hansson C, Hallberg IR, Risberg B, et al. Health-related quality of life after revascularization for peripheral arterial occlusive disease: long-term follow-up. J Adv Nurs. 2005;51(3):227–235
  51. Klevsgård R, Hallberg IR, Risberg B, et al. The effects of successful intervention on quality of life in patients with varying degrees of lower-limb ischaemia. Eur J Vasc Endovasc Surg. 2000;19:238–245
  52. Klevsgård R, Froberg BL, Risberg B, et al. Nottingham Health Profile and Short-Form 36 Health Survey questionnaires in patients with chronic lower limb ischemia: before and after revascularization. J Vasc Surg. 2002;36:310–317
  53. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation. 2004;109:733–739
  54. Polit FD, Beck CT. Nursing research (Principles and methods). 7 ed.. Philadelphia: JB Lippincott Company; 2004;
  55. Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J. 1986;292:746–750
  56. Fontaine VR, Kim M, Kicny R. Die chirurgische Behandlung der peripheren Durchblutungsstorungen. Helvetica Chirurgica Acta. 1954;5/6:499–533
  57. Bloemenkamp DG, Mali WP, Tanis BC, et al. Functional health and well-being of relatively young women with peripheral arterial disease is decreased but stable after diagnosis. J Vasc Surg. 2003;38:104–110
  58. McDermott MM, Greenland P, Guralnik JM, et al. Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med. 2003;18:461–467
  59. Arseven A, Guralnik JM, O’Brien E, et al. Peripheral arterial disease and depressed mood in older men and women. Vasc Med. 2001;6:229–234
  60. Ponte E, Cattinelli S. Quality of life in a group of patients with intermittent claudication. Angiology. 1996;47:247–251
  61. Criqui MH, Denenberg JO, Langer RD, et al. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997;2:221–226
  62. McDermott MM, Greenland P, Liu K, et al. Sex differences in peripheral arterial disease: leg symptoms and physical functioning. J Am Geriatr Soc. 2003;51:222–228
  63. Binnie A, Perkins J, Hands L. Exercise and nursing therapy for patients with intermittent claudication. J Clin Nurs. 1999;8(2):190–200
  64. Stewart AHR, Lamont PM. Exercise for intermittent claudication: supervised programmes should be universally available. Br Med J. 2001;323(7315):703–704
  65. Altura BM, Zou LY, Altura BT, et al. Beneficial vs. detrimental actions of ethanol on hearth and coronary vascular muscle: roles of Mg2+ and Ca2+. Alcohol. 1996;13(5):499–513
  66. Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329:1829–1834

 This study was supported by the Academy of Finland and the Finnish Association of Caring Sciences.

PII: S1062-0303(06)00067-7

doi: 10.1016/j.jvn.2006.06.015

Journal of Vascular Nursing
Volume 24, Issue 4 , Pages 102-115 , December 2006

Article Tools

* Image Usage & Resolution